BioLite, Inc.   Report issue

For profit Phase 2
Founded: Taipei Taiwan (2006)

Organization Overview

First Clinical Trial
2012
NCT01774045
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

BioLite, Inc.